VNDA R&D Expenses
Vanda Pharmaceuticals Inc · R&D Expenses
VNDA R&D Expenses
Latest reported$116.96Mperiod ending
VNDA TTM R&D Expenses ($16.89M → $116.96M)
TTM R&D Expenses
High-resolution chart · PNG
VNDA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 116,957,000 | |
| 101,994,000 | |
| 109,271,000 | |
| 100,105,000 | |
| 94,318,000 | |
| 88,989,000 | |
| 74,431,000 | |
| 78,930,000 | |
| 78,754,000 | |
| 78,740,000 | |
| 76,823,000 | |
| 70,938,000 | |
| 79,195,000 | |
| 84,038,000 | |
| 85,770,000 | |
| 86,647,000 | |
| 81,443,000 | |
| 80,201,000 | |
| 75,363,000 | |
| 70,881,000 | |
| 63,526,000 | |
| 56,181,000 | |
| 55,577,000 | |
| 53,802,000 | |
| 52,851,000 | |
| 50,898,000 | |
| 48,649,000 | |
| 48,497,000 | |
| 48,540,000 | |
| 47,456,000 | |
| 43,594,000 | |
| 40,826,000 | |
| 39,614,000 | |
| 37,396,000 | |
| 38,547,000 | |
| 36,007,000 | |
| 33,123,000 | |
| 32,175,000 | |
| 29,156,000 | |
| 30,289,000 | |
| 32,969,000 | |
| 32,215,000 | |
| 29,145,000 | |
| 25,150,000 | |
| 18,877,000 | |
| 16,445,000 | |
| 19,230,000 | |
| 20,700,000 | |
| 25,025,000 | |
| 27,493,000 | |
| 28,190,000 | |
| 32,585,000 | |
| 34,718,000 | |
| 41,226,000 | |
| 45,446,000 | |
| 45,385,000 | |
| 43,400,000 | |
| 36,909,000 | |
| 28,996,000 | |
| 22,261,618 | |
| 18,159,807 | |
| 14,564,352 | |
| 12,337,999 | |
| 10,769,424 | |
| 8,789,219 | |
| 13,581,269 | |
| 13,873,966 | |
| 15,180,466 | |
| 16,880,906 | |
| 15,166,220 | |
| 23,935,541 | |
| 32,950,733 | |
| 43,032,557 | |
| 47,745,473 | |
| 47,234,867 | |
| 42,600,120 | |
| 38,268,257 | |
| 47,174,282 | |
| 52,070,777 | |
| 49,379,839 | |
| 43,929,694 | |
| 28,501,367 | |
| 16,890,615 |